共 50 条
- [31] Phase I dose escalation study of the CDK4/6 inhibitor palbociclib in combination with the MEK inhibitor PD0325901 in patients with RAS mutant solid tumorsCANCER RESEARCH, 2017, 77Shapiro, Geoffrey I.论文数: 0 引用数: 0 h-index: 0Hilton, John论文数: 0 引用数: 0 h-index: 0Gandi, Leena论文数: 0 引用数: 0 h-index: 0Chau, Nicole论文数: 0 引用数: 0 h-index: 0Cleary, James论文数: 0 引用数: 0 h-index: 0Wolanski, Andrew论文数: 0 引用数: 0 h-index: 0Anderson, Adrienne论文数: 0 引用数: 0 h-index: 0Beardslee, Brian论文数: 0 引用数: 0 h-index: 0Hassinger, Faith论文数: 0 引用数: 0 h-index: 0Bhushan, Ketki论文数: 0 引用数: 0 h-index: 0Downey, Elizabeth论文数: 0 引用数: 0 h-index: 0Gibson, Joseph论文数: 0 引用数: 0 h-index: 0Pruitt-Thompson, Solida论文数: 0 引用数: 0 h-index: 0Muzikansky, Alona论文数: 0 引用数: 0 h-index: 0Barry, Suzanne论文数: 0 引用数: 0 h-index: 0Feeney, Nora论文数: 0 引用数: 0 h-index: 0Paweletz, Cloud论文数: 0 引用数: 0 h-index: 0Oxnard, Geoffrey论文数: 0 引用数: 0 h-index: 0Supko, Jeffrey论文数: 0 引用数: 0 h-index: 0Janne, Pasi论文数: 0 引用数: 0 h-index: 0Wong, Kwok-Kin论文数: 0 引用数: 0 h-index: 0Johnson, Bruce论文数: 0 引用数: 0 h-index: 0
- [32] A phase 1 dose-escalation study of BBI503, a first-in-class cancer stemness kinase inhibitor in adult patients with advanced solid tumorsJOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)Laurie, Scott Andrew论文数: 0 引用数: 0 h-index: 0机构: Ottawa Hosp Canc Ctr, Ottawa, ON, CanadaJonker, Derek J.论文数: 0 引用数: 0 h-index: 0机构: Ottawa Hosp Canc Ctr, Ottawa, ON, CanadaEdenfield, William Jeffery论文数: 0 引用数: 0 h-index: 0机构: Ottawa Hosp Canc Ctr, Ottawa, ON, CanadaStephenson, Joe论文数: 0 引用数: 0 h-index: 0机构: Ottawa Hosp Canc Ctr, Ottawa, ON, CanadaKeller, Deborah论文数: 0 引用数: 0 h-index: 0机构: Ottawa Hosp Canc Ctr, Ottawa, ON, CanadaHitron, Matthew论文数: 0 引用数: 0 h-index: 0机构: Ottawa Hosp Canc Ctr, Ottawa, ON, CanadaLi, Wei论文数: 0 引用数: 0 h-index: 0机构: Ottawa Hosp Canc Ctr, Ottawa, ON, CanadaLi, Youzhi论文数: 0 引用数: 0 h-index: 0机构: Ottawa Hosp Canc Ctr, Ottawa, ON, CanadaGada, Keyur论文数: 0 引用数: 0 h-index: 0机构: Ottawa Hosp Canc Ctr, Ottawa, ON, CanadaGao, Yuan论文数: 0 引用数: 0 h-index: 0机构: Ottawa Hosp Canc Ctr, Ottawa, ON, CanadaLi, Chiang论文数: 0 引用数: 0 h-index: 0机构: Ottawa Hosp Canc Ctr, Ottawa, ON, Canada
- [33] First-in-human phase I dose-escalation study of the oral selective C-met inhibitor EMD 1204831 in patients with advanced solid tumors.JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)Amin, Hesham M.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USAFalchook, Gerald Steven论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USAFu, Siqing论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USAHong, David S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USATsimberidou, Apostolia Maria论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USANaing, Aung论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USAWheler, Jennifer J.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USAPiha-Paul, Sarina Anne论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USAJanku, Filip论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USAKlevesath, Manfred B.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USAJego, Virginie论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USAJohne, Andreas论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USAKurzrock, Razelle论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
- [34] First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion StudyCANCER DISCOVERY, 2018, 8 (02) : 184 - 195Sullivan, Ryan J.论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USAInfante, Jeffrey R.论文数: 0 引用数: 0 h-index: 0机构: Tennessee Oncol, Sarah Cannon Res Inst, Nashville, TN USA Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USAJanku, Filip论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USAWong, Deborah Jean Lee论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USASosman, Jeffrey A.论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Univ, Med Ctr, Nashville, TN USA Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USAKeedy, Vicki论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Univ, Med Ctr, Nashville, TN USA Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USAPatel, Manish R.论文数: 0 引用数: 0 h-index: 0机构: Florida Canc Specialists, Sarah Cannon Res Inst, Sarasota, FL USA Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USAShapiro, Geoffrey I.论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USAMier, James W.论文数: 0 引用数: 0 h-index: 0机构: Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USATolcher, Anthony W.论文数: 0 引用数: 0 h-index: 0机构: South Texas Accelerated Res Therapeut, San Antonio, TX USA Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:Flaherty, Keith论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USABuchbinder, Elizabeth论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USACarvajal, Richard D.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USAVarghese, Anna M.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USALacouture, Mario E.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USARibas, Antoni论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USAPatel, Sapna P.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USADeCrescenzo, Gary A.论文数: 0 引用数: 0 h-index: 0机构: BioMed Valley Discover Inc, Kansas City, MO USA Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USAEmery, Caroline M.论文数: 0 引用数: 0 h-index: 0机构: BioMed Valley Discover Inc, Kansas City, MO USA Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USAGroover, Anna L.论文数: 0 引用数: 0 h-index: 0机构: BioMed Valley Discover Inc, Kansas City, MO USA Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USASaha, Saurabh论文数: 0 引用数: 0 h-index: 0机构: BioMed Valley Discover Inc, Kansas City, MO USA Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USAVarterasian, Mary论文数: 0 引用数: 0 h-index: 0机构: BioMed Valley Discover Inc, Kansas City, MO USA Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USAWelsch, Dean J.论文数: 0 引用数: 0 h-index: 0机构: BioMed Valley Discover Inc, Kansas City, MO USA Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USAHyman, David M.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USALi, Bob T.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA
- [35] Phase I Dose-Escalation Study of the Dual PI3K-mTORC1/2 Inhibitor Gedatolisib in Combination with Paclitaxel and Carboplatin in Patients with Advanced Solid TumorsCLINICAL CANCER RESEARCH, 2021, 27 (18) : 5012 - 5019Colombo, Ilaria论文数: 0 引用数: 0 h-index: 0机构: Oncol Inst Southern Switzerland, Med Oncol Serv, EOC, CH-6500 Bellinzona, Switzerland Oncol Inst Southern Switzerland, Med Oncol Serv, EOC, CH-6500 Bellinzona, SwitzerlandGenta, Sofia论文数: 0 引用数: 0 h-index: 0机构: Oncol Inst Southern Switzerland, Med Oncol Serv, EOC, CH-6500 Bellinzona, Switzerland Oncol Inst Southern Switzerland, Med Oncol Serv, EOC, CH-6500 Bellinzona, SwitzerlandMartorana, Federica论文数: 0 引用数: 0 h-index: 0机构: Oncol Inst Southern Switzerland, Med Oncol Serv, EOC, CH-6500 Bellinzona, Switzerland Oncol Inst Southern Switzerland, Med Oncol Serv, EOC, CH-6500 Bellinzona, SwitzerlandGuidi, Monia论文数: 0 引用数: 0 h-index: 0机构: Lausanne Univ Hosp, Serv Clin Pharmacol, Lausanne, Switzerland Lausanne Univ, Lausanne, Switzerland Lausanne Univ Hosp, Ctr Res & Innovat Clin Pharmaceut Sci, Lausanne, Switzerland Oncol Inst Southern Switzerland, Med Oncol Serv, EOC, CH-6500 Bellinzona, SwitzerlandFrattini, Milo论文数: 0 引用数: 0 h-index: 0机构: Cantonal Inst Pathol, Mol Pathol Lab, Locarno, Switzerland Oncol Inst Southern Switzerland, Med Oncol Serv, EOC, CH-6500 Bellinzona, SwitzerlandSamartzis, Eleftherios Pierre论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Zurich, Ctr Canc, Dept Gynecol & Gynecol, Zurich, Switzerland Oncol Inst Southern Switzerland, Med Oncol Serv, EOC, CH-6500 Bellinzona, SwitzerlandBrandt, Simone论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Zurich, Inst Pathol & Mol Pathol, Zurich, Switzerland Oncol Inst Southern Switzerland, Med Oncol Serv, EOC, CH-6500 Bellinzona, SwitzerlandGaggetta, Sheila论文数: 0 引用数: 0 h-index: 0机构: Oncol Inst Southern Switzerland, Med Oncol Serv, EOC, CH-6500 Bellinzona, Switzerland Oncol Inst Southern Switzerland, Med Oncol Serv, EOC, CH-6500 Bellinzona, SwitzerlandMoser, Laura论文数: 0 引用数: 0 h-index: 0机构: Oncol Inst Southern Switzerland, Med Oncol Serv, EOC, CH-6500 Bellinzona, Switzerland Oncol Inst Southern Switzerland, Med Oncol Serv, EOC, CH-6500 Bellinzona, SwitzerlandPascale, Mariarosa论文数: 0 引用数: 0 h-index: 0机构: Ente Ospedaliero Cantonale EOC, Clin Trial Unit, Bellinzona, Switzerland Oncol Inst Southern Switzerland, Med Oncol Serv, EOC, CH-6500 Bellinzona, SwitzerlandTerrot, Tatiana论文数: 0 引用数: 0 h-index: 0机构: Ente Ospedaliero Cantonale EOC, Clin Trial Unit, Bellinzona, Switzerland Oncol Inst Southern Switzerland, Med Oncol Serv, EOC, CH-6500 Bellinzona, SwitzerlandSessa, Cristiana论文数: 0 引用数: 0 h-index: 0机构: Oncol Inst Southern Switzerland, Med Oncol Serv, EOC, CH-6500 Bellinzona, Switzerland Oncol Inst Southern Switzerland, Med Oncol Serv, EOC, CH-6500 Bellinzona, SwitzerlandStathis, Anastasios论文数: 0 引用数: 0 h-index: 0机构: Oncol Inst Southern Switzerland, Med Oncol Serv, EOC, CH-6500 Bellinzona, Switzerland Univ Svizzera Italiana, Fac Biomed Sci, Lugano, Switzerland Oncol Inst Southern Switzerland, Med Oncol Serv, EOC, CH-6500 Bellinzona, Switzerland
- [36] Phase I, multi-center, dose-escalation and dose-expansion study of IMP7068, a WEE1 inhibitor, in patients with advanced solid tumorsANNALS OF ONCOLOGY, 2023, 34 : S466 - S466Lin, C-C.论文数: 0 引用数: 0 h-index: 0机构: NTUH Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan NTUH Natl Taiwan Univ Hosp, Dept Oncol, Taipei, TaiwanGrewal, J.论文数: 0 引用数: 0 h-index: 0机构: Norton Canc Inst, Med Oncol, Louisville, KY USA NTUH Natl Taiwan Univ Hosp, Dept Oncol, Taipei, TaiwanBaranda, J. C.论文数: 0 引用数: 0 h-index: 0机构: Univ Kansas, Clin Res Ctr, Med Oncol Dept, Kansas City, KS USA NTUH Natl Taiwan Univ Hosp, Dept Oncol, Taipei, TaiwanSchneider, R. E.论文数: 0 引用数: 0 h-index: 0机构: Mary Crowley Canc Res Ctr, Outpatient Evaluat & Treatment Ctr Texas Oncol, Dallas, TX USA NTUH Natl Taiwan Univ Hosp, Dept Oncol, Taipei, TaiwanZhang, J.论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Shanghai Canc Ctr, Dept Oncol, Shanghai, Peoples R China NTUH Natl Taiwan Univ Hosp, Dept Oncol, Taipei, TaiwanBai, L-Y.论文数: 0 引用数: 0 h-index: 0机构: China Med Univ Hosp, Div Hematol & Oncol, New Taipei, Taiwan NTUH Natl Taiwan Univ Hosp, Dept Oncol, Taipei, TaiwanYeh, Y-M.论文数: 0 引用数: 0 h-index: 0机构: NCKUH Natl Cheng Kung Univ Hosp, Oncol, Tainan, Taiwan NTUH Natl Taiwan Univ Hosp, Dept Oncol, Taipei, TaiwanSommerhalder, D.论文数: 0 引用数: 0 h-index: 0机构: NEXT Oncol, Oncol, San Antonio, TX USA NTUH Natl Taiwan Univ Hosp, Dept Oncol, Taipei, TaiwanLi, G.论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Gynaecol Oncol, Wuhan, Peoples R China NTUH Natl Taiwan Univ Hosp, Dept Oncol, Taipei, TaiwanShen, L.论文数: 0 引用数: 0 h-index: 0机构: Beijing Canc Hosp, Dept Digest Oncol, Beijing, Peoples R China NTUH Natl Taiwan Univ Hosp, Dept Oncol, Taipei, TaiwanHsu, H-C.论文数: 0 引用数: 0 h-index: 0机构: Linkou Chang Gung Mem Hosp, Chang Gung Med Fdn, Oncol, Taoyuan, Taiwan NTUH Natl Taiwan Univ Hosp, Dept Oncol, Taipei, TaiwanAlese, O.论文数: 0 引用数: 0 h-index: 0机构: Emory Univ Hosp, Hematol & Med Oncol, 1364 Clifton Rd NE, Atlanta, GA 30322 USA NTUH Natl Taiwan Univ Hosp, Dept Oncol, Taipei, TaiwanYin, R.论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Womens & Childrens Hosp, West China Univ Hosp 2, Dept Oncol & Chemoradiotherapy, Chengdu, Peoples R China NTUH Natl Taiwan Univ Hosp, Dept Oncol, Taipei, TaiwanHsieh, C-Y.论文数: 0 引用数: 0 h-index: 0机构: IMPACT Therapeut Inc Shanghai, Clin Dev, Shanghai, Peoples R China NTUH Natl Taiwan Univ Hosp, Dept Oncol, Taipei, TaiwanCai, S. X.论文数: 0 引用数: 0 h-index: 0机构: IMPACT Therapeut Inc Shanghai, Dev, Shanghai, Peoples R China NTUH Natl Taiwan Univ Hosp, Dept Oncol, Taipei, TaiwanTian, Y. E.论文数: 0 引用数: 0 h-index: 0机构: IMPACT Therapeut Inc Shanghai, Res, Shanghai, Peoples R China NTUH Natl Taiwan Univ Hosp, Dept Oncol, Taipei, TaiwanXia, H.论文数: 0 引用数: 0 h-index: 0机构: IMPACT Therapeut Inc Shanghai, Clin Dev, Shanghai, Peoples R China NTUH Natl Taiwan Univ Hosp, Dept Oncol, Taipei, TaiwanLi, B.论文数: 0 引用数: 0 h-index: 0机构: IMPACT Therapeut Inc Shanghai, Clin Dev, Shanghai, Peoples R China NTUH Natl Taiwan Univ Hosp, Dept Oncol, Taipei, TaiwanZhang, M.论文数: 0 引用数: 0 h-index: 0机构: IMPACT Therapeut Inc Shanghai, Clin Dev, Shanghai, Peoples R China NTUH Natl Taiwan Univ Hosp, Dept Oncol, Taipei, TaiwanZhang, C.论文数: 0 引用数: 0 h-index: 0机构: IMPACT Therapeut Inc Shanghai, Clin Dev, Shanghai, Peoples R China NTUH Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan
- [37] Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumorsCancer Chemotherapy and Pharmacology, 2020, 85 : 673 - 683Anthony W. Tolcher论文数: 0 引用数: 0 h-index: 0机构: South Texas Accelerated Research Therapeutics,Division of Hematology and Oncology, Moores Cancer CenterRazelle Kurzrock论文数: 0 引用数: 0 h-index: 0机构: South Texas Accelerated Research Therapeutics,Division of Hematology and Oncology, Moores Cancer CenterVincente Valero论文数: 0 引用数: 0 h-index: 0机构: South Texas Accelerated Research Therapeutics,Division of Hematology and Oncology, Moores Cancer CenterRene Gonzalez论文数: 0 引用数: 0 h-index: 0机构: South Texas Accelerated Research Therapeutics,Division of Hematology and Oncology, Moores Cancer CenterRebecca S. Heist论文数: 0 引用数: 0 h-index: 0机构: South Texas Accelerated Research Therapeutics,Division of Hematology and Oncology, Moores Cancer CenterAntoinette R. Tan论文数: 0 引用数: 0 h-index: 0机构: South Texas Accelerated Research Therapeutics,Division of Hematology and Oncology, Moores Cancer CenterJulie Means-Powell论文数: 0 引用数: 0 h-index: 0机构: South Texas Accelerated Research Therapeutics,Division of Hematology and Oncology, Moores Cancer CenterTheresa L. Werner论文数: 0 引用数: 0 h-index: 0机构: South Texas Accelerated Research Therapeutics,Division of Hematology and Oncology, Moores Cancer CenterCarlos Becerra论文数: 0 引用数: 0 h-index: 0机构: South Texas Accelerated Research Therapeutics,Division of Hematology and Oncology, Moores Cancer CenterChenxi Wang论文数: 0 引用数: 0 h-index: 0机构: South Texas Accelerated Research Therapeutics,Division of Hematology and Oncology, Moores Cancer CenterCathrine Leonowens论文数: 0 引用数: 0 h-index: 0机构: South Texas Accelerated Research Therapeutics,Division of Hematology and Oncology, Moores Cancer CenterShanker Kalyana-Sundaram论文数: 0 引用数: 0 h-index: 0机构: South Texas Accelerated Research Therapeutics,Division of Hematology and Oncology, Moores Cancer CenterJoseph F. Kleha论文数: 0 引用数: 0 h-index: 0机构: South Texas Accelerated Research Therapeutics,Division of Hematology and Oncology, Moores Cancer CenterJennifer Gauvin论文数: 0 引用数: 0 h-index: 0机构: South Texas Accelerated Research Therapeutics,Division of Hematology and Oncology, Moores Cancer CenterAnthony M. D’Amelio论文数: 0 引用数: 0 h-index: 0机构: South Texas Accelerated Research Therapeutics,Division of Hematology and Oncology, Moores Cancer CenterCatherine Ellis论文数: 0 引用数: 0 h-index: 0机构: South Texas Accelerated Research Therapeutics,Division of Hematology and Oncology, Moores Cancer CenterNageatte Ibrahim论文数: 0 引用数: 0 h-index: 0机构: South Texas Accelerated Research Therapeutics,Division of Hematology and Oncology, Moores Cancer CenterLi Yan论文数: 0 引用数: 0 h-index: 0机构: South Texas Accelerated Research Therapeutics,Division of Hematology and Oncology, Moores Cancer Center
- [38] Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumorsCANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (04) : 673 - 683Tolcher, Anthony W.论文数: 0 引用数: 0 h-index: 0机构: South Texas Accelerated Res Therapeut, San Antonio, TX 78229 USA NEXT Oncol, San Antonio, TX 78229 USA Texas Oncol, 5206 Res Dr, San Antonio, TX 78240 USA South Texas Accelerated Res Therapeut, San Antonio, TX 78229 USAKurzrock, Razelle论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Diego, Moores Canc Ctr, Div Hematol & Oncol, San Diego, CA 92103 USA South Texas Accelerated Res Therapeut, San Antonio, TX 78229 USAValero, Vincente论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Div Canc Med, Houston, TX 77030 USA South Texas Accelerated Res Therapeut, San Antonio, TX 78229 USAGonzalez, Rene论文数: 0 引用数: 0 h-index: 0机构: Univ Colorado, Canc Ctr, Melanoma Res Clin, Div Med Oncol, Aurora, CO USA South Texas Accelerated Res Therapeut, San Antonio, TX 78229 USAHeist, Rebecca S.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA 02114 USA South Texas Accelerated Res Therapeut, San Antonio, TX 78229 USATan, Antoinette R.论文数: 0 引用数: 0 h-index: 0机构: Rutgers Canc Inst New Jersey, New Brunswick, NJ USA Atrium Hlth, Levine Canc Inst, Charlotte, NC USA South Texas Accelerated Res Therapeut, San Antonio, TX 78229 USAMeans-Powell, Julie论文数: 0 引用数: 0 h-index: 0机构: Sarah Cannon Res Inst, Nashville, TN USA South Texas Accelerated Res Therapeut, San Antonio, TX 78229 USAWerner, Theresa L.论文数: 0 引用数: 0 h-index: 0机构: Univ Utah, Dept Med, Huntsman Canc Inst, Div Med Oncol, Salt Lake City, UT 84112 USA South Texas Accelerated Res Therapeut, San Antonio, TX 78229 USABecerra, Carlos论文数: 0 引用数: 0 h-index: 0机构: Baylor Univ, Med Ctr, US Oncol, Texas Oncol, Dallas, TX USA South Texas Accelerated Res Therapeut, San Antonio, TX 78229 USAWang, Chenxi论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Collegeville, PA USA South Texas Accelerated Res Therapeut, San Antonio, TX 78229 USALeonowens, Cathrine论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Collegeville, PA USA Cathrine Leonowens Consulting LLC, Sanford, NC USA South Texas Accelerated Res Therapeut, San Antonio, TX 78229 USAKalyana-Sundaram, Shanker论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Collegeville, PA USA South Texas Accelerated Res Therapeut, San Antonio, TX 78229 USAKleha, Joseph F.论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Array Biopharma, Boulder, CO USA South Texas Accelerated Res Therapeut, San Antonio, TX 78229 USAGauvin, Jennifer论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA South Texas Accelerated Res Therapeut, San Antonio, TX 78229 USAD'Amelio, Anthony M.论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA South Texas Accelerated Res Therapeut, San Antonio, TX 78229 USAEllis, Catherine论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Collegeville, PA USA South Texas Accelerated Res Therapeut, San Antonio, TX 78229 USAIbrahim, Nageatte论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Collegeville, PA USA Merck & Co Inc, Kenilworth, NJ USA South Texas Accelerated Res Therapeut, San Antonio, TX 78229 USAYan, Li论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Collegeville, PA USA Brii Biosci Ltd, San Francisco, CA USA South Texas Accelerated Res Therapeut, San Antonio, TX 78229 USA
- [39] Phase I Dose-escalation and Pharmacokinetic Trial of Lapatinib (GW572016), a Selective Oral Dual Inhibitor of ErbB-1 and-2 Tyrosine Kinases, in Japanese Patients with Solid TumorsJAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (02) : 116 - 123Nakagawa, Kazuhiko论文数: 0 引用数: 0 h-index: 0机构: Kinki Univ, Sch Med, Osaka 5890014, Japan Kinki Univ, Sch Med, Osaka 5890014, JapanMinami, Hironobu论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp E, Chiba, Japan Kinki Univ, Sch Med, Osaka 5890014, JapanKanezaki, Masayuki论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Tokyo, Japan Kinki Univ, Sch Med, Osaka 5890014, JapanMukaiyama, Akihira论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Tokyo, Japan Kinki Univ, Sch Med, Osaka 5890014, JapanMinamide, Yoshiyuki论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline, Tokyo, Japan Kinki Univ, Sch Med, Osaka 5890014, JapanUejima, Hisao论文数: 0 引用数: 0 h-index: 0机构: Kinki Univ, Sch Med, Osaka 5890014, Japan Kinki Univ, Sch Med, Osaka 5890014, JapanKurata, Takayasu论文数: 0 引用数: 0 h-index: 0机构: Kinki Univ, Sch Med, Osaka 5890014, Japan Kinki Univ, Sch Med, Osaka 5890014, JapanNogami, Toshiji论文数: 0 引用数: 0 h-index: 0机构: Kinki Univ, Sch Med, Osaka 5890014, Japan Kinki Univ, Sch Med, Osaka 5890014, JapanKawada, Kenji论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp E, Chiba, Japan Kinki Univ, Sch Med, Osaka 5890014, JapanMukai, Hirofumi论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp E, Chiba, Japan Kinki Univ, Sch Med, Osaka 5890014, JapanSasaki, Yasutsuna论文数: 0 引用数: 0 h-index: 0机构: Saitama Med Sch, Saitama, Japan Kinki Univ, Sch Med, Osaka 5890014, JapanFukuoka, Masahiro论文数: 0 引用数: 0 h-index: 0机构: Kinki Univ, Sch Med, Osaka 5890014, Japan Kinki Univ, Sch Med, Osaka 5890014, Japan
- [40] First-in-human study of HMPL-295, an ERK1/2 inhibitor, in patients with advanced solid tumors: Dose-escalation results of monotherapyJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Yu, Xianjun论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai, Peoples R ChinaZhang, Jian论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai, Peoples R ChinaSun, Yuping论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai, Peoples R ChinaDeng, Yanhong论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai, Peoples R ChinaGuo, Shuangshuang论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai, Peoples R ChinaHong, Wei论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai, Peoples R ChinaShi, Si论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai, Peoples R ChinaLiu, Rujiao论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai, Peoples R ChinaGao, Shuiping论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai, Peoples R ChinaDang, Qi论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai, Peoples R ChinaZhang, Jianwei论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai, Peoples R ChinaSu, Weiguo论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai, Peoples R ChinaShi, Michael论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai, Peoples R ChinaFan, Songhua论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai, Peoples R ChinaZhang, Bo论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai, Peoples R ChinaPan, Beiqing论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai, Peoples R ChinaJia, Xiaoyun论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai, Peoples R ChinaWang, Jian论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai, Peoples R ChinaZhong, Chen论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai, Peoples R ChinaMa, Luguang论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai, Peoples R China